Harvard Bioscience Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Harvard Bioscience, Inc. (HBIO) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents4.114.284.517.828.328.348.17
Cash & Short-Term Investments4.114.284.517.828.328.348.17
Accounts Receivable14.8716.1016.7121.8317.7720.7021.46
Inventory23.2524.7226.4427.5922.2622.0625.09
Other Current Assets2.903.943.474.343.362.473.11
Total Current Assets45.1249.0451.1261.5851.7053.5757.83
Non-Current Assets
Property, Plant & Equipment (Net)11.248.759.1810.3111.7213.245.90
Long-Term Investments0.003.500.000.000.000.000.00
Goodwill56.3257.0756.2657.6958.590.000.00
Intangible Assets11.1316.0421.0127.3933.150.000.00
Other Non-Current Assets2.746.477.455.171.092.271.82
Total Non-Current Assets81.5388.3394.24100.76104.55111.30110.78
Total Assets126.64137.37145.36162.34156.25164.87168.61
Current Liabilities
Accounts Payable4.795.556.454.915.975.3410.17
Short-Term Debt36.965.863.813.241.720.000.00
Current Portion of Long-Term Debt36.965.863.813.241.720.000.00
Accrued Liabilities2.264.433.876.534.150.000.00
Deferred Revenue3.814.513.374.273.770.000.00
Other Current Liabilities5.9910.623.624.017.486.702.62
Total Current Liabilities54.9626.5423.2525.3221.0525.3125.49
Non-Current Liabilities
Long-Term Debt6.3835.5043.0145.1053.7755.1454.81
Deferred Tax Liabilities0.710.780.591.561.900.000.00
Other Non-Current Liabilities1.261.481.010.492.850.753.29
Total Non-Current Liabilities8.3537.7549.8953.6358.5257.8660.40
Total Liabilities63.3064.2973.1478.9479.5783.1885.89
Stockholders' Equity
Common Stock0.440.430.450.450.440.000.00
Retained Earnings-158.01-159.80-142.19-132.67-145.45-124.58-119.89
Accumulated Other Comprehensive Income-15.67-14.19-15.05-10.03-13.07-12.69-13.53
Treasury Stock0.000.000.000.00-10.67-10.67-10.67
Additional Paid-in Capital236.58232.44229.01225.65232.36229.19226.38
Shares Outstanding44.0743.3942.0841.140.000.000.00
Total Stockholders' Equity63.3473.0772.2283.4076.6881.6982.72
Total Liabilities & Equity126.64137.37145.36162.34156.25164.87168.61